期刊
PHARMACOLOGY RESEARCH & PERSPECTIVES
卷 9, 期 5, 页码 -出版社
JOHN WILEY & SONS LTD
DOI: 10.1002/prp2.795
关键词
CNS-related peptides; neurodegeneration; protective autoimmunity
资金
- National Scientific and Technical Research Council of Argentina [PIP 2015-00163]
- National Agency for the Promotion of Science and Technology [PICT 2016-2727, PICT 2016-0531]
Neurodegenerative diseases are characterized by the progressive loss of neurons and the interaction between the immune system and the central nervous system plays a key role in neuronal damage. Protective autoimmunity concept and CNS-related peptides with immunomodulatory neuroprotective effects have been proposed as potential therapeutic options for NDD.
Neurodegenerative diseases (NDD) are disorders characterized by the progressive loss of neurons affecting motor, sensory, and/or cognitive functions. The incidence of these diseases is increasing and has a great impact due to their high morbidity and mortality. Unfortunately, current therapeutic strategies only temporarily improve the patients' quality of life but are insufficient for completely alleviating the symptoms. An interaction between the immune system and the central nervous system (CNS) is widely associated with neuronal damage in NDD. Usually, immune cell infiltration has been identified with inflammation and is considered harmful to the injured CNS. However, the immune system has a crucial role in the protection and regeneration of the injured CNS. Nowadays, there is a consensus that deregulation of immune homeostasis may represent one of the key initial steps in NDD. Dr. Michal Schwartz originally conceived the concept of protective autoimmunity (PA) as a well-controlled peripheral inflammatory reaction after injury, essential for neuroprotection and regeneration. Several studies suggested that immunizing with a weaker version of the neural self-antigen would generate PA without degenerative autoimmunity. The development of CNS-related peptides with immunomodulatory neuroprotective effect led to important research to evaluate their use in chronic and acute NDD. In this review, we refer to the role of PA and the potential applications of active immunization as a therapeutic option for NDD treatment. In particular, we focus on the experimental and clinical promissory findings for CNS-related peptides with beneficial immunomodulatory effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据